Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes,abnormal glucose tolerance and metabolic syndrome
Free accessResearch articleFirst published online May, 2005
Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes,abnormal glucose tolerance and metabolic syndrome
The aim of this study was to assess the performance of the Finnish Diabetes Risk Score as a screening tool for undetected type 2 diabetes (T2D), abnormal glucose tolerance (AGT) and metabolic syndrome in the general population.
In a cross-sectional, population-based survey, a total of 4, 622 subjects aged 45–74 years were invited to a health examination that included an oral glucose tolerance test. Full data with risk score estimate and glucose tolerance status were available for 2, 966 subjects without a prior history of diabetes.
The risk score was associated with the presence of previously undiagnosed T2D, AGT, metabolic syndrome and cardiovascular risk factors. The area under the receiver operating curve for the prevalence of undiagnosed diabetes was 0.72 in men and 0.73 in women. The sensitivity using a cutoff risk score of 11 to identify undiagnosed diabetes was 66% in men and 70% in women; the corresponding false-positive rates were 31% and 39%, respectively. The area under the receiver operating curve for detecting the metabolic syndrome was 0.72 in men and 0.75 in women.
The Finnish Diabetes Risk Score can be used as a self-administered test to screen subjects at high risk for T2D. It can also be used in the general population and clinical practice to identify undetected T2D, AGT and the metabolic syndrome.
1. Decode Study Group.Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care2003;26:61–9.
2.
2. Borch-Johnsen K, Colagiuri S, Balkau B et al.Creating a pandemic of prediabetes: the proposed new diagnostic criteria for impaired fasting glycaemia. Diabetologia2004;47:1396–402.
3.
3. Edelstein SL, Knowler WC, Bain RP et al.Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes1997;46:701–10.
4.
4. Eastman RC, Cowie CC, Harris MI.Undiagnosed diabetes or impaired glucose tolerance and cardiovascular risk. Diabetes Care1997;20:127–8.
5.
5. Decode Study Group.Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med2001;161:397–405.
6.
6. Jarrett RJ, McCartney P, Keen H.The Bedford survey: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics. Diabetologia1982;22:79–84.
7.
7. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M.Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med1998;339:229–34.
8.
8. UK Prospective Diabetes Study (UKPDS).VIII. Study design, progress and performance. Diabetologia1991;34:877–90.
9.
9. Saydah SH, Loria CM, Eberhardt MS, Brancati FL.Subclinical states of glucose intolerance and risk of death in the U.S. Diabetes Care2001;24:447–53.
10.
10. Qiao Q, Jousilahti P, Eriksson J, Tuomilehto J.Predictive properties of impaired glucose tolerance for cardiovascular risk are not explained by the development of overt diabetes during follow-up. Diabetes Care2003;26:2910–14.
11.
11. Tuomilehto J, Lindström J, Eriksson JG et al.Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med2001;344:1343–50.
12.
12. Pan XR, Li GW, Hu YH et al.Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care1997;20:537–44.
13.
13. Knowler WC, Barrett-Connor E, Fowler SE et al.Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med2002;346:393–403.
14.
14. Lindström J, Tuomilehto J.The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care2003;26:725–31.
15.
15. Vartiainen E, Jousilahti P, Alfthan G, Sundvall J, Pietinen P, Puska P.Cardiovascular risk factor changes in Finland, 1972–1997. Int J Epidemiol2000;29:49–56.
16.
16. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): A major international collaboration. WHO MONICA Project Principal Investigators. J Clin Epidemiol1988;41:105–14.
17.
17. WHO: Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation. Part 1: Diagnosis and classification of diabetes mellitus. Geneva: World Health Organization. Department of Noncommunicable Disease Surveillance, 1999.
18.
18. Adult Treatment Panel III: Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation2002;106:3143–421.
19.
19. StataCorp: Stata Statistical Software: Release 8.0. College Station, TX, Stata Corporation, 2003.
20.
20. Griffin SJ, Little PS, Hales CN, Kinmonth AL, Wareham NJ.Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diabetes Metab Res Rev2000;16:164–71.
21.
21. Swinburn BA, Metcalf PA, Ley SJ.Long-term (5-year) effects of a reduced-fat diet intervention in individuals with glucose intolerance. Diabetes Care2001;24:619–24.
22.
22. Glumer C, Carstensen B, Sandbaek A, Lauritzen T, Jorgensen T, Borch-Johnsen K.A Danish diabetes risk score for targeted screening: the Inter99 study. Diabetes Care2004;27:727–33.
23.
23. Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM.The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care2003;26:3153–9.
24.
24. Park PJ, Griffin SJ, Sargeant L, Wareham NJ.The performance of a risk score in predicting undiagnosed hyperglycemia. Diabetes Care2002;25:984–8.
25.
25. Baan CA, Ruige JB, Stolk RP et al.Performance of a predictive model to identify undiagnosed diabetes in a health care setting. Diabetes Care1999;22:213–19.
26.
26. Finnish Diabetes Association. Programme for the prevention of type 2 diabetes in Finland. http://www.diabetes.fi/english/prevention/programme/index.html. Tampere, 2003.
27.
27. Spijkerman AM, Adriaanse MC, Dekker JM et al.Diabetic patients detected by population-based stepwise screening already have a diabetic cardiovascular risk profile. Diabetes Care2002;25:1784–9.
28.
28. Isomaa B, Almgren P, Tuomi T et al.Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care2001;24:683–9.
29.
29. Hunt K, Williams K, Haffner S, Stern M.Predicting impaired glucose tolerance among individuals with non-diabetic fasting glucose value: The San Antonio Heart Study. Diabetes2002;2:SA229.
